Endo International (ENDP) Tops Q1 EPS by 10c, Revenues Beat; Offers FY19 EPS/Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Endo International (ENDP) Tops Q1 EPS by 10c, Revenues Beat; Offers FY19 EPS/Revenue Guidance

Endo Reports First-Quarter 2019 Financial Results

May 9, 2019 6:30 AM EDT

DUBLIN, May 9, 2019 /PRNewswire/ --

First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile Injectables revenues increased 25 percent to $270 million compared to first-quarter 2018 revenues of $216 million First-quarter 2019 Branded Pharmaceuticals - Specialty Products revenues increased 19 percent to $115 million compared to first-quarter 2018 revenues of $97 million Company affirms 2019 financial guidance

Endo International plc (NASDAQ: ENDP) today reported first-quarter 2019 financial results, including:

Revenues of $720 million, an increase of 3 percent compared to first-quarter 2018 revenues of $701... More